Compare VNDA & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
TAT Technologies Ltd is a provider of solutions and services to the aerospace and defence industries focused mainly on the four segments: Original equipment manufacturing (OEM); MRO services for heat transfer; MRO services for aviation components; Overhaul and coating of jet engine components. The company designs, develops, and manufactures Heat Exchangers, Cooling Systems, Cold Plates, Vapor-Cycle Air Conditioning Systems (for both land and airborne applications), and flow accessories.